A polydopamine nanomedicine used in photothermal therapy for liver cancer knocks down the anti-cancer target NEDD8-E3 ligase ROC1 (RBX1)
Abstract Knocking down the oncogene ROC1 with siRNA inhibits the proliferation of cancer cells by suppressing the Neddylation pathway. However, methods for delivering siRNA in vivo to induce this high anticancer activity with low potential side effects are urgently needed. Herein, a folic acid (FA)-...
Main Authors: | Zhanxia Zhang, Junqian Zhang, Jianhui Tian, Hegen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-10-01
|
Series: | Journal of Nanobiotechnology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12951-021-01063-4 |
Similar Items
-
Reactive oxygen species (ROS)-response nanomedicine through knocking down a novel therapeutic target NEDD8-conjugating enzyme UBC12 (UBE2M) in the treatment of liver cancer
by: Zhanxia Zhang, et al.
Published: (2021-06-01) -
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions
by: Dong-Jun Fu, et al.
Published: (2023-07-01) -
Neddylation inhibitor MLN4924 suppresses cilia formation by modulating AKT1
by: Hongmei Mao, et al.
Published: (2019-03-01) -
Fission yeast neddylation ligase Dcn1 facilitates cohesin cleavage and chromosome segregation at anaphase
by: Lan Lin, et al.
Published: (2017-06-01) -
RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival
by: Sun Yi, et al.
Published: (2009-08-01)